Cargando…
SAT-LB110 Sulfonylurea-Induced Hypoglycemia: To Use Octreotide or Not
Background: Sulfonylurea poisoning can cause sustained hypoglycemia refractory to intravenous dextrose. Traditional treatment for sulfonylurea induced hypoglycemia includes intravenous dextrose and glucagon as well as diazoxide in refractory cases. Octreotide is recommended for sulfonylurea poisonin...
Autores principales: | Romeu, Jose, Dodge, Hannah, Mears, Chad, Kozlow, Erin, Patel, Ravi, Vunnam, Rama, Bhatt, Dhirisha, Sahu, Nitasa, Golamari, Reshma, Jain, Rohit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209006/ http://dx.doi.org/10.1210/jendso/bvaa046.2092 |
Ejemplares similares
-
Role of Octreotide in Sulfonylurea-Induced Hypoglycemia
por: Zafar, Sheema, et al.
Publicado: (2021) -
Rare enough ? Cardiac Device‐related pocket Infection due to Mycobacterium fortuitum
por: Golamari, Reshma, et al.
Publicado: (2021) -
SAT-LB118 Euglycemic Diabetic Ketoacidosis in Type 2 Diabetes Mellitus
por: Arao, Kevin A, et al.
Publicado: (2020) -
MON-LB110 A Phase 2 Evaluation of a Ready-To-Use Liquid Stable Continuous Subcutaneous Glucagon Infusion for the Treatment of Hypoglycemia Associated Autonomic Failure
por: Pettus, Jeremy H, et al.
Publicado: (2020) -
SAT-679 Autoimmune Hypoglycemia: A Treatment Challenge
por: Santana, Nadyeschka Angelique Rivera, et al.
Publicado: (2020)